Open access
Sep 2026
MYC-Hyperactivated Osteosarcoma Models Exhibit Resistance to Cabozantinib plus TIGIT Blockade
Sarah S. Kappa, Tajhal D. Patel, Bikesh K. Nirala et al.
· bioRxiv · 0 citations